WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > HBCS
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Webinar
HEALTH TECHNOLOGY
HCA Healthcare, Inc. | October 07, 2022
HCA Healthcare, Inc. one of the nation’s leading healthcare providers, announced that it will give $1.5 million to Tennessee State University to create scholarship opportunities for students enrolled in the Dr. Levi Watkins, Jr. Institute and the Department of Computer Science within the College of Engineering. This gift is part of the organization’s larger commitment to give $10 million over three years to Historically Black Colleges and Universities (HBCUs) and Hispanic Serving ...
FUTURE OF HEALTHCARE
Ascensus | April 11, 2022
Ascensus—whose technology and expertise help millions of people save for retirement, education, and healthcare—and Newport, the Walnut Creek, California-based retirement services provider—announced today that the two companies have closed their previously announced merger, the first step in their journey together as a combined organization. The union combines the capabilities and talents of two market leaders in tax-advantaged savings and related services, serving ...
Athenahealth | June 12, 2020
Athenahealth announced this week that it had launched an embedded telehealth tool to allow practitioners to conduct virtual visits without having to download separate software or use another third-party app. The Watertown, Massachusetts-based cloud computing vendor said athenaTelehealth – which is free for its athenaOne electronic health record tool customers until September 30 – enables providers to more easily conduct HIPAA-compliant telehealth visits within practice workflows, fro...
GNS Healthcare | July 22, 2020
GNS Healthcare (GNS), a leading AI and simulation company, presents results that validate the use of AI to accurately classify tumors based on their immunogenicity and predict response to immune checkpoint inhibitor (ICI) therapy using real-world data. The study showcases the power of causal AI to capture biomarkers and mechanisms, in addition to PD(L)1 and tumor mutation burden (TMB), that are consistent with known immunology. These markers, including CXCL13 upregulation and STK11 mutation, are...
Whitepaper
DIGITAL HEALTHCARE, MEDICAL DEVICES
Video
Article
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE